This site gives you access to a set of useful materials that will remind you and your patients about the warnings and precautions relating to tofacitinib and appropriate actions to take.
Please confirm you are a healthcare professional
This page gives you access to a set of useful materials that will remind you and your patients about the warnings and precautions relating to XELJANZ (tofactinib citrate) and appropriate actions to take
Prescriber brochure
The prescriber brochure provides succinct but comprehensive guidance on all important aspects of prescribing tofacitinib: therapeutic indications and contraindications; dosage; administration; monitoring; laboratory parameters; precautions and warnings; patient counseling; reporting of adverse events as well as a summarised risk management plan.
Patient alert card
This pocket-sized leaflet is designed for patients so they can carry important safety information with them. It summarises the safety information patients should understand before starting treatment with tofacitinib. It also describes what they should look out for during treatment and when to contact their doctor if they have any concerns or problems related to treatment.
Tofacitinib prescriber treatment initiation checklist
This leaflet is provided to remind prescribers about risks associated with the use of tofacitinib and the recommended steps to take before the first dose is administered
Tofacitinib prescriber treatment maintenance checklist
This provides prescribers with a checklist of treatment risks to monitor while patients are being treated with tofacitinib and the recommended tests to perform during treatment.
Patient information leaflet
This information leaflet is provided for patients who have been prescribed tofacitinib and presents key information about correct use and advice on actions to take to ensure they achieve optimal outcomes.
Summary of product characteristics
The tofacitinib summary of product characteristics (SmPC) provides information for healthcare professionals on how to use a medicine safely and effectively. It is updated as new efficacy or safety data emerge.
Date of preparation: 02/2018
XELZ-MT-WEB, V1.0